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It has been reported that a human murine mammary tumour virus (MMTV)-like virus (HMLV), which may be an endogenous human
retrovirus (HERV), occurs in the human breast cancer cell lines T47D and MCF-7 and, in 38% of human breast cancer biopsies. As the
aetiology of most breast cancers remains unknown, it is important to verify these observations in differing breast cancer populations
worldwide. Thus, we sought to determine the genetic relationships between HMLVs, MMTVs, and HERVs, and to investigate the
association between HMLVs and breast cancer biopsies from South London, UK. Phylogenetic analyses of the env/pol region indicated
that HMLVs are indistinct from MMTVs, and that MMTVS/HMLVs exhibit only low sequence homologies with HERVs. A search of the
human genome confirmed that HMLVs are not endogenous. Using MMTV polymerase chain reaction (PCR) primers described previously,
we amplified DNA from all cell lines except MCF-7 and from 7 of 44 (16%) breast cancer biopsies. A restriction fragment length
polymorphism assay was designed to distinguish between HMLVs and MMTVs, and upon analyses, PCR amplicons appeared to be
HMLVs. To confirm these findings, amplicons from the T47D cell line and from four randomly selected breast cancer patients were
sequenced. Of 106 DNA sequences obtained, 103 were homologous with a short arm of human chromosome (Chr) 3 (3p13), two with
Chromosome 4, and one with Chromosome 8. None of the sequences exhibited significant nucleotide homology with MMTVs, HMLVs,
or with HERVs (all < 50%). Thus, we conclude that (i) HMLVs are integral members of the MMTV family; (ii) MMTVs/HMLVs are
genetically distinct from HERVs; (iii) MMTV/HMLV DNA is not present in human breast cancer cell lines or clinical biopsies in our
locality.
D 2003 Elsevier Inc. All rights reserved.Keywords: MMTV; HMLV; HERVs; Breast cancer
susceptibility factors for breast cancer include being femaleIntroduction
Breast cancer is a common disease of women with
800000 incident cases worldwide (Parkin et al., 1999),
with about 30000 new cases diagnosed and 13000 deaths
each year in England and Wales (ONS, 1999). This
malignancy is heterogeneous with at least 16 distinct
histopathological types of which ductal, lobular, and tubu-
lar are most common (Millis et al., 1999). Important0042-6822/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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E-mail address: john.cason@kcl.ac.uk (J. Cason).and resident in northern Europe or north America (Kelsey,
1979), having an early menarche (Pike et al., 1981); a late
menopause (Henderson, 1990); nulliparity, late prima grav-
iditas, high socioeconomic status and exposure to ionizing
radiation (Bodian, 1993; Dupont and Page, 1985; Harris et
al., 1992; Kelsey and Gammon, 1991; London et al.,
1992); a previous history of invasive carcinoma, carcinoma
in situ, or atypical hyperplasia of the breast (Bodian, 1993;
Dupont and Page, 1985; Harris et al., 1992; Kelsey and
Gammon, 1991; London et al., 1992); long-term oestrogen
therapy or oral contraceptive usage; obesity in postmeno-
pausal women; and a high fat diet (Grady et al., 1992;
Harris et al., 1992; Kelsey and Gammon, 1990, 1991).
However, aside from the small proportion of familial breast
C. Mant et al. / Virology 318 (2004) 393–404394cancers—where inherited mutations principally in the
BRCA-1 or BRCA-2 genes, are causal (Colditz et al.,
1993)—the aetiology of sporadic cases of breast cancer
remains unknown.
Viruses are believed to cause at least 15% of all human
cancers (Butel, 2000) and recently, a viral aetiology for
some cases of human breast cancer has been suggested withFig. 1. Phylogram of the DNA amplified by the PCR demonstrating the close g
individual examples of unique MMTV and HMLV (indicated on A, B & C) env/p
database accession numbers for samples A–S are given in Table 4. DNA sequenc
phylogenetic tree obtained using ClustalW. Bootstrap values exceeding 70% (from
difference per nucleotide (0.01 = 1 nucleotide change per 100 residues).reports of a type B retrovirus present in malignant cells
(Wang et al., 1995). A retroviral cause for some breast
tumours in mice was discovered over 60 years ago with the
identification of murine mammary tumour virus (MMTV;
Bittner, 1942). Many workers then, and subsequently, have
postulated that a similar virus (human MMTV-like virus,
HMLV) might be causal for human breast cancers. Initialenetic relationship between unique MMTV and HMLV sequences. A–S:
ol DNA sequences edited down to the region amplified in the PCR. Actual
es were originally obtained from data Banks, aligned, bootstrapped and the
1000 reiterations) are indicated, the scale bar (left) represents nucleotide
Table 1
Nucleotide homologies (%) between HMLVs and MMTVs
HMLV MMTV
B C D E F G H I J K L M N O P Q R S
HMLV A 94 93 98 95 95 95 94 94 94 94 94 93 94 94 93 95 94 94
B 96 94 95 99 97 98 97 97 97 92 97 97 98 95 99 97 97
C 93 94 97 97 98 97 96 98 91 95 96 96 95 97 96 96
MMTV D 95 95 95 94 94 95 94 94 93 94 94 93 95 94 94
E 96 95 95 95 95 95 94 94 95 95 94 95 95 95
F 98 98 98 98 98 93 98 98 99 96 100 98 98
G 98 97 99 98 92 96 97 97 96 98 98 97
H 98 98 99 92 97 97 98 96 98 98 97
I 97 99 92 96 97 97 96 98 97 96
J 98 92 96 97 97 96 98 98 97
K 92 96 97 98 96 98 98 97
L 91 92 92 91 93 92 92
M 97 97 95 98 96 96
N 97 96 98 97 97
O 96 98 97 97
P 96 96 98
Q 98 98
R 97
These data were obtained using ClustalW after gap stripping and represent
the percentage of nucleotide homology on retrieved sequences correspond-
ing to the 656-bp section between the primers within the env/pol genes. For
the accession details of these sequences, refer to Table 4.
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infection in that, MMTV-like virus particles were observed
in human breast cancer biopsies (Holder and Wells, 1983),
cell lines (Segev et al., 1985), and breast milk (Dion et al.,
1987); expression of proteins immunologically cross-reac-
tive with MMTV antigens were detected in human breast
cancer biopsies (Segev et al., 1985); and there was serologic
evidence of exposure to an MMTV-like agent in women
with breast cancer and their healthy daughters, though rarely
in control sera (Holder and Wells, 1983). Whilst provoca-
tive, these findings were subject to the criticisms that patient
numbers were often low and recruited from limited geo-
graphical locations, and that not all studies of sero-reactivity
to MMTV proteins could confirm an association with
malignancy (Kovarik et al., 1989). Moreover, molecular
evidence for the presence of an HMLV agent was hard to
obtain.
Genetic evidence linking HMLVs with breast cancer was
difficult to establish as it is unclear whether human endog-
enous retroviruses (HERVs) include examples of HMLVs or
just exhibited sufficient nucleotide similarity to permit
cross-hybridisation. HERVs constitute about 0.6% of the
human genome, are randomly distributed on all chromo-
somes, and are often replication incompetent. Nevertheless,
examples of HERV biological function have been described
and some are transcriptionally active (Ting et al., 1992).
Some HERVs reportedly exhibit sequence similarities with
MMTVs (Ono, 1986) and are confusingly referred to as
HERVs related to MMTV (HMLs, e.g., HML-2 and HML-
6). One of these (HML-2) is highly expressed in a multifocal
ductal breast cancer (Yin et al., 1997). The problem of
differentiating between HERVs and HMLVs was overcome
by using polymerase chain reaction (PCR) primers in the
env/pol section of the MMTV provirus, as this region has
low nucleotide sequence homology with a HERV-K virus
(Wang et al., 1995).
Wang et al. (1995) reported that HMLV DNA occurred in
120 of 314 (38%) unselected human breast carcinomas from
the USA, but in only 1 of 140 (1%) normal breast specimens
from reduction mammoplasties. Similar results were
obtained by Etkind et al. (2000), who found 27 of 73
(37%) breast cancers, though not histologically normal
tissues, were positive for HMLV DNA. Investigation of
paraffin-embedded samples produced similar data with 36%
of breast cancers from the USA (Wang et al., 1995) and 37%
from Italy (Pogo et al., 1999) positive for HMLV DNA. In
the last of these studies, HMLV positivity was not associ-
ated with clinical, pathological, or biological parameters
other than expression of the laminin receptor, a marker for
invasiveness and poorer prognosis. The same group
detected HMLV RNA in 66% of DNA positive cancers by
reverse transcriptase PCR (Vlahakis et al., 1998). This
HMLV appeared to be of exogenous origin as proviral
DNA was present in cancerous tissue, but not in histolog-
ically normal regions of the same biopsy. Melana et al.
(2001) formed a similar conclusion after they detectedHMLV DNA in 32 of 106 (30%) breast cancers, but in
only 1 of 106 (1%) histologically normal breast tissues.
Given the potential importance of an association between
a retrovirus with some cases of human breast cancer, it is
logical to determine whether these observations can be
confirmed in other patient populations. We therefore inves-
tigated the genetic relationships among HMLVs, MMTVs,
HMLs, and HERVs, as well as the occurrence of HMLV
DNA in cell lines and in 44 human breast cancer biopsies
from South London, UK.Results
Genetic relatedness of HMLVs, MMTVs, and HERVs
We compared the env/pol region of unique isolates of
these viruses archived in databanks. Phylogenetic analyses
of HMLV and MMTV sequences revealed that they are
closely related to one another, and that HMLVs do not form
a unique ‘human’ branch (Fig. 1): there is also a high degree
of nucleotide homology (all >91%) between HMLV and
MMTV sequences (Table 1). HMLV sequence A was
closely related to MMTV sequence D (98% homology),
HMLV B resembled MMTV sequences F and Q (both
99%), and HMLV sequence C resembled MMTVs H and
K (both 98%). Subsequent analyses demonstrated that
HERVs are genetically distinct from HMLVs/MMTVs
(Fig. 2) and only demonstrated low homologies with HMLV
(e.g., versus sequence A: all < 6%; Table 2), yet usually
demonstrated homologies in excess of 90% with members
of their own families. Similarly, HML-2 and HML-6 are
Fig. 2. MMTVs/HMLVs are genetically distinct from the major HERV families. Phylogram demonstrating the relationship betweenMMTVs/HMLVs (left A–S)
and human endogenous retroviruses of the E, H, K&W families. MMTV/HMLVare numbered as before, see Table 2 for the HERV sequences and their accession
numbers.
C. Mant et al. / Virology 318 (2004) 393–404396unrelated to MMTV/HMLVs and phylogenetically resemble
HERVs. A BLAST search of the human genome failed to
identify regions of homology with either HMLVs or
MMTVs (data not shown).
PCR and RFLP analyses
We established a PCR for HMLV DNA using T47D
cells and optimised the amplification conditions so thatwe could produce the discrete product at a lower cell
number than was possible using the conditions of Etkind
et al. (2000), providing us with an assay with an analytic
sensitivity of 25 T47D cells/Al. Between each breast
cancer biopsy section we cut sections of apple to control
for the potential carry-over of genetic material. None of
the apple sections were positive for B-globin DNA or
HMLV DNA, indicating that no cross-contamination had
occurred. All breast cancer biopsies and all cell lines were
Table 2
Nucleotide homologies within HERVs and between an HMLV sequence (A)
E H K W
262463 HML6 19 10 C33 734E12 HH 18.3 18.2 I C4 18890 104 103 108 HML2 HB9 HB8 HB6 HB5 HB2 RT- AZ5213 A549-2 MCF7 JUR3 HepG2-2 3.8 C7.1
A 5 6 2 2 3 2 3 2 2 5 5 2 3 4 3 3 2 2 5 2 2 2 2 2 5 2 2 4 2
E 2624643 4 4 4 32 3 31 5 6 9 3 5 7 2 5 6 4 2 8 4 4 4 4 4 2 2 2 4 4
H HML6 3 4 7 4 4 2 2 2 4 2 2 3 2 2 2 2 3 4 2 2 2 2 3 2 2 2 2
19 96 9 96 4 2 5 5 4 5 2 2 2 2 4 6 4 4 4 4 6 4 6 6 4 4 4
10 10 94 4 2 5 5 4 5 2 2 2 2 4 6 4 2 4 4 2 4 4 4 4 5 4
C33 7 60 7 4 10 6 7 5 3 7 6 4 4 4 4 4 4 5 5 2 4 4 4 4
734E12 4 2 2 2 4 2 2 2 2 2 5 5 6 5 5 5 6 4 6 5 2 6 5
HH 4 4 4 4 4 4 4 4 4 3 7 3 3 3 4 3 3 6 3 3 3 3
K 18.3 94 96 46 98 96 97 97 97 6 4 2 4 6 6 3 7 4 3 6 3 6
18.2 95 20 93 96 96 92 97 6 4 2 4 6 6 3 7 4 3 6 3 6
I 20 95 97 97 97 97 3 3 3 3 3 3 3 3 3 3 3 3 3
C4 20 45 20 20 20 5 2 5 5 5 5 3 5 2 4 5 5 5
18890 96 96 96 96 6 4 2 4 6 6 3 7 4 3 6 3 6
104 97 98 3 3 2 2 4 3 3 3 3 3 3 3 3 3
103 98 98 3 3 2 4 3 3 3 3 3 3 3 3 3
108 100 3 3 2 4 3 3 3 3 3 3 3 3 3
HML2 3 3 2 4 3 3 3 3 3 3 3 3 3
W HB9 94 93 93 99 97 95 95 94 94 94 93 99
HB8 92 92 93 92 93 93 95 94 92 91 94
HB6 92 93 91 93 94 96 93 92 91 93
HB5 93 91 93 93 93 93 91 90 93
HB2 97 94 95 94 98 94 93 99
RT-2 93 94 93 96 93 92 97
AZ521-3 98 95 96 92 91 95
A549-2 95 96 93 92 95
MCF7 96 92 91 94
JUR3 94 93 98
HepG2 95 94
3-8 93
This alignment represents a 533-bp region of the env/pol of HERVS and HMLV (sequence A) within the region subsequently amplified by PCR accessio numbers: A: HMLV sequence A (AF346816). (i) HERV
E: HE-26246 (AF026246). (ii) HERV-H: HH (U92816)c33.6; HH-19 (AF108843); HH-10 (AF108841); HH-c33 (U92820); HML6 (AF069508); HH-7 4E12 (AJ289710). (iii) HERV-K: HK-18.3 (AF333073);
HK-18.2 (AF333069); HK-(I) (AB047209); HK-C4 (HSU07856); HK-18890 (HER18890); HK-104 (AF164612); HK-103 (AF164611); HK-108 (AF1 614); HK-HML2 (AF074086). (iv) HERV-W: HW-HB9
(AB079509); HW-HB8 (AB079508); HW-HB6 (AB079506); HW-HB5 (AB079505); HW-HB2 (AB079502); HW-RT-2 (AB055416); HW-AZ52 3 (AB055413); HW-A549-2 (AB055412); HW-MCF7
(AB054088); HW-JUR3 (AB054087); HW-HepG2-2 (AB054086); HW-3-8 (AB050999); HW-C7.1 (AF156963).
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C. Mant et al. / Virology 318 (2004) 393–404398positive for h-globin DNA. Every cell line—except MCF-
7—was positive using MMTV primers, and of the 44
breast cancer biopsies studied, seven (16%) were
repeatedly (n = 6) positive (Figs. 3A and B). All positive
breast cancer samples were from ductal carcinomas,
though there was no association with lesion grade (data
not shown).
RLFP testing of amplicons from cell lines and breast
cancer biopsies revealed all were cut only by Msp1
(indicating that none contained MMTV DNA) and sug-
gests that HMLV sequence B may be present (Fig. 3B). ToFig. 3. PCR AND RFLP results for cell lines and breast samples. A: representat
clinical samples using the MMTV primers. MW: molecular weight markers; U: u
enzyme Msp1 is able to digest the PCR product. B: Table of the RFLP results +: po
in RFLP analyses.confirm these data, we characterised a subset of samples
by DNA sequencing (below). After all PCRs, RFLP and
DNA sequencing analyses of human biopsies and cell lines
had been completed, we obtained MMTV DNA (ATTC
plasmid p203) and were able to demonstrate that the PCR
amplifies native MMTV DNA which is only sensitive to
digestion by BamH1 in RFLP analyses (Fig. 3B). A
spiking experiment—using a previously MMTV-negative
breast cancer biopsy sample—indicated that the PCR was
able to detect between 24 and 2.4 copies of MMTV (Fig.
4) and that the presence of breast tissue was not inhibitoryive results for PCR and RFLP analyses of DNA amplified from some and
ndigested PCR product. The next three lanes show that only the restriction
sitive in PCR or for the presence of that particular restriction endonucleases
Fig. 4. Sensitivity of the MMTV PCR with and without breast cancer tissue. A: with breast tissue, B: without breast tissue. MW: molecular weight markers.
Lane 1: molecular biology grade water; lane 2, MMTV plasmid (2.4108 copies); lanes 3-11 sequential ten fold dilutions of plasmid (i.e. lane 3: 2.4108
copies through to lane 11: 0.24 copies).
C. Mant et al. / Virology 318 (2004) 393–404 399when compared to the same assay run without breast
tissue.
DNA Sequencing
One hundred and ten DNA sequences were obtained
from T47D cells, MCF-10 cells, and from four breast
cancer biopsies (Table 3). One hundred and three sequen-
ces had high (>99%) homologies with an ‘antisense’ region
of the short arm of human chromosome (Chr) 3 region
3p13. Irrespective of the source, all Chr3 sequences were
similar to each other as illustrated phylogenetically for the
102 complete reads (Fig. 5). Use of the NCBI Evidence
Viewer revealed that the region of human Chr3 cor-
responding to this sequence contains no predicted mRNA
exons; furthermore, the complete human DNA RP11-
433A10 contig does not contain significant homology with
MMTV or with HERVs (data not shown). Four sequences
(MCF-10, n = 1; T47D, n = 2; biopsy #10, n = 1) wereTable 3
Summary of DNA sequences obtained
Sample No. of BLAST results
acceptable reads
Chromosome 3a Other
MCF-10 cells 21 21 0
T47D cells 19 18 1 chromosome 8b
Biopsy #10 17 17
(1 truncated)
0
Biopsy #53 18 18 0
Biopsy #66 15 15 0
Biopsy #75 16 14 2 chromosome 4c
Total 106 103 3
a RP11-433A10 contig [AC112219.2], nucleotides 124301p123665:
corresponding to nucleotides 1225004p 1225640 of Chr3.
b Human Chr8 (nt 35457! 36176 of clone CTD2-3179G6).
c Human Chr4 (nt 25242! 25648 of clone RP11-722M1).excluded from phylogenetic analyses because they either
contained large numbers of ambiguity codes or contained
large truncations; nevertheless, all four exhibited homology
with parts of Chr3 (RP11-433A10 contig). Two sequences
from biopsy #75 exhibited homologies of 97% and 99%,
respectively, with a 406-bp region of human Chr4 and one
from the T47D cell line with a region of human Chr8.
None of the sequences exhibited significant nucleotide
homology (< 50%) with MMTV, HMLV, or HERV sequen-
ces, and phylogenetic analyses indicated that these two
viral groups were unrelated to Chr3 sequences. Sequencing
of two cloned amplicons obtained by PCR of the MMTV-
containing plasmid (p203) revealed both contained bona
fide MMTV DNA identical to sequence K AF228552:
Table 4).Discussion
There has recently been interest that a proportion of human
breast cancers are caused by viral infection with one candi-
date virus being a human analogue of MMTV (Wang et al.,
1995). In this report, we have demonstrated the three reported
HMLVs are integral members of the MMTV family and do
not constitute a unique ‘human’ branch of MMTVs. This
observation leads us to conclude that there is no distinct
lineage of HMLVs and that they are in fact MMTVs. We next
demonstrated that the MMTV/HMLV family is genetically
distinct from the HERVs and that there is no significant
homology betweenMMTV/HMLV sequences and the human
genome. This result would be consistent with the proposal
that HMLV has an exogenous source (Pogo et al., 1999;
Wang et al., 1995), and exhibits dissimilar epidemiological
characteristics to the endogenous form of MMTV in mice.
This last point is supported by epidemiological studies of
humans that have demonstrated that there is no association
Fig. 5. Phylogram showing the close relationship between chromosome 3 sequences obtained using the MMTV PCR primers. Results for all chromosome three
sequences obtained are shown. Each sequence is identified by the original clinical sample (e.g. #53) or cell-line designation followed by the clone number (e.g.
#53-10, #MCF-9 etc.). Bootstrap values are omitted for clarity due to limited space in this figure. The scale bar (bottom) denotes the distance representing 1
nucleotide change per 100 base pairs. Genbank accession numbers for these sequences are AY367173–AY367274.
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Table 4
Restriction enzyme cut-sites of genetically distinct HMLV and MMTV
sequences
Accession number Source Restriction site
BamH1 Ase1 Msp1
A AF346816 HMLV  + 
B AF243039 HMLV   +
C AF239172 HMLV +  
D XM_127093 MMTVa  + 
E BC003207 MMTV +  
F XM_132588 MMTVa   
G AF228550 MMTVb +  
H X01811 MMTV +  
I K00556 MMTVb +  
J AF228551 MMTVb +  
K AF228552 MMTVb +  
L D16249 MMTVc   
M XM_135310 MMTVa   
N AF263910 MMTVd   
O M22028 MMTV   
P AF043688 MMTV +  
Q XM_132587 MMTVa   
R M15122 MMTVe +  
S AF071010 MMTV +  
MMTV: murine mammary tumour virus; HMLV: human MMTV-like virus;
+: restriction endonuclease cut site present, or  : absent in the region
amplified by the PCR. 1: MMTV derived from C57/BL6J mice; 2:C3H/Hen
mice; 3:JYG mice; 4:RIII mice; 5:BR6 mice.
C. Mant et al. / Virology 318 (2004) 393–404 401between being breast fed as an infant and susceptibility to
breast cancer in later life (Titus-Ernstoff et al., 1998).
In this study, the same PCR primers were used as those
groups that have reported HMLV in breast cancers. Ampli-
cons were obtained for 7 of 44 (16%) breast cancer samples,
but upon testing by RFLP, all contained an Msp1 site,
suggesting they were similar to HMLV sequence B. How-
ever, DNA sequencing revealed that only human chromo-
somal DNA had been amplified and, in 96.2% of cases, this
was homologous to human Chr3. Amplified Chr3 DNA
sequences exhibited minor differences between clones orig-
inating from the same sample which could have arisen from:
(i) hereditary differences between maternal and paternal
chromosomes; (ii) host acquired mutations; and (iii) our
use of Taq. DNA polymerase introduced artefacts. Never-
theless, these differences were minimal.
The explanations for the disparity between the findings
of this study and those of some other groups may include
the following: (i) before and during the testing of clinical
samples, our laboratory had never contained MMTV,
murine cell lines, or murine genetic material, consequen-
tially, in this study, there was absolutely no potential for
contamination of human samples with endogenous or
exogenous MMTV DNA; (ii) HMLV may have been
present in our samples, but only at low copy number. This
has been suggested by Wang et al. (1995), who used
nested PCRs combined with Southern blotting to identify
HMLV. Nevertheless, it is unlikely that we would not have
obtained at least one HMLV sequence, given the number
of DNA sequences investigated. Indeed, statistically, the 19Chr3 sequences from the T47D cell line gives us a
confidence of at least 94.7% that HMLV DNA is not
present in this cell line. (iii) There may be marked,
geographically, differences in the distribution of HMLV
within human populations as, initially, only small patient
populations in New York State, USA, and in Italy were
investigated (Etkind et al., 2000; Vlahakis et al., 1998;
Wang et al., 1995). Recently, this has been highlighted in
studies from Vietnam where just 1% of breast cancers were
shown to be positive in PCRs for HMLV DNA, whereas in
Australia the figure was 42% (Ford et al., 2003). Con-
versely, an absence of MMTV has been reported in 17
ductal carcinomas despite being tested in seven MMTV
PCRs (Zangen et al., 2002) and, in 50 Austrian breast
cancer patients (Witt et al., 2003). Furthermore, the latter
group tested 22 human breast cancer cell lines—including
T47D and MCF-7—and found none contained MMTV
DNA (Witt et al., 2003).
It might be argued that because we have used slightly
different PCR conditions to Etkind et al. (2000), the
sensitivity and specificity of the PCR had been altered in
such a way as to permit false priming, resulting in the
amplification of host genome DNA, predominantly Chr3.
However, we were subsequently able to demonstrate that
our PCR conditions could amplify MMTV DNA at a higher
sensitivity to those described by Etkind et al. (2000).
We have therefore demonstrated (i) that HMLVs are
members of the MMTV family and these viruses are
phylogenetically distinct to the major HERV families;
(ii) an absence of HMLV DNA in the T47D, MCF-7,
and MCF-10 breast cancer cell lines; and (iii) the absence
of MMTV/HMLV proviral DNA in breast cancer biopsies.
This last finding leads us to conclude that MMTV/HMLVs
are not causally involved in the aetiology of breast cancers
in South London, UK, a finding that is confirmed by the
recent critical observation that human cells lack the
appropriate transferrin receptor for MMTV cell entry
(Ross et al., 2002).Materials and methods
Phylogenetic and DNA analyses
MMTV, HMLV, and HERV viral DNA sequences from
databases were aligned with the env/pol regions
corresponding to the region amplified in the PCR (below)
after being gap-stripped. Alignments and phylogenetic trees
were produced and bootstrapped using ClustalW (version
1.82: http://www.ebi.ac.uk/). Phylograms were visualised
using TreeView (1.6.6: http://www.taxonomy. zoology.gla.
ac.uk/rod/treeview.html). Experimentally derived DNA
sequences were converted into the same ‘sense’ orientation,
using the Reverse/Complimentarity programme (http://
www.ualberta.ca/%Estohard/javascript/rev_comp.html).
Sequences were then subjected to standard nucleotide
Fig. 6. Map of the MMTV/HMLV genome showing the region amplified by PCR. LTR: long terminal repeat; POL: polymerase; ENV: envelope; Sag: super
antigen:kbp: kilobase pairs.
Fig. 7. Restriction fragment length polymorphism analyses map. Schematic
map indicating the unique restriction endonucleases cut-sites in the 686 bp
fragment amplified from MMTV and HMLV; as well as the size of the
fragments produced after digestion.
C. Mant et al. / Virology 318 (2004) 393–404402BLAST searches (http://www.ncbi.nlm. nih.gov/BLAST) to
define homologies with those deposited at GenBank, Euro-
pean Molecular Biology Laboratory, and the DNA database
of Japan.
Human cell lines
We investigated reportedly HMLV-positive (T47D cells,
from a human ductal carcinoma and MCF-7 cells, an
epithelial breast adenocarcinoma) and -negative (MCF-10
human epithelial cells from a patient with benign fibrocystic
breast disease) cell lines for the presence of HMLVs (Wang
et al., 1995). Other human cell lines—of undetermined
HMLV status—were studied and included: human embry-
onic kidney (HEK) cells, SiHa cells (a cervical cancer cell
line), and NC37 cells (a lymphoblastoid cell line). A
plasmid construct (p203) containing the env sequence of
MMTV was used to check the specificity and sensitivity of
the PCR. The cell lines and plasmid were obtained directly
from the American Type Culture Collection (ATCC).
Biological samples
Snap-frozen biopsies of breast carcinomas from 44 female
patients (median age 58, range 34 to 84 years) were randomly
selected from samples collected between 1995 and 1999 in a
tissue bank established by the Cancer Research U.K. Hedley
Atkins Breast Pathology Laboratory, Guy’s Hospital, London
UK. Of the 44 patients, the majority (80%) were in situ ductal
carcinomas (grade 1, 22%; grade II, 32%; and grade III,
46%), one a medullary carcinoma, one of mixed histology,
and the rest were of unknown status. Permission to study
these samples was provided by the Research Ethics Commit-
tee of Guy’s Hospital, London. Each biopsy was mounted inOCT frozen tissue matrix and three 10-Am cryostat sections
collected into an Eppendorf tube for PCR. Between each
human clinical biopsy sample, the cryostat blade was cleaned
with 70% (v/v) aqueous ethanol and eight 10-Am sections of
frozen, OCT-mounted, apple (Malus domestica, ‘Granny
Smith’: which contains no mammalian viruses) were cut.
The last three sections of apple were subjected to PCR
analyses for HMLVand h-globin DNA to control for poten-
tial ‘carry over’ of material between sequential human
clinical samples during sectioning.
Polymerase chain reactions
All samples were treated with Proteinase K in a 20-
Al volume and then 1 Al of this was subjected to PCR in a
final volume of 25 Al to amplify h-globin DNA (using GH20
and PCO4 primers; Saiki et al., 1986) or HMLV DNA using
MMTV primers described in the literature (Etkind et al.,
C. Mant et al. / Virology 318 (2004) 393–404 4032000), namely, (5V! 3V) TACATCTGCCTGTGTTAC (up-
stream) and CCTCACTGCCAGATC (downstream). The
cycling conditions for the MMTV PCR were: 1 cycle at 94
jC for 5 min; 40 cycles at 94 jC for 30 s, 55 jC for 30 s, and
72 jC for 45 s; followed by a final extension at 72 jC for 5
min (0.5 units Thermophilus aquaticus DNA polymerase
[Taq] 2.5 mM MgCl2, 250 AM dNTPs, and 250 nM of each
primer). The h-globin PCR was included to determine if
samples contained nonspecific PCR inhibitors and also to
establish whether the samples contained sufficient DNA for
analyses. For all PCRs, care was taken to avoid cross-
contamination of biopsy samples by use of: (i) four geo-
graphically remote rooms (for reagent preparation, test sam-
ple manipulations and addition of reagents, PCR
amplification, and agarose gel electrophoresis); (ii) good
laboratory practice (use of plugged pipette tips and not
preparing samples after dealing with amplicons on the same
day); (iii) appropriate controls (one sample blank; one reagent
blank; one water blank, and one aliquot of T47D cells and an
equal number of apple controls per run of clinical biopsy
samples); (iv) strict data acceptance criteria (all controls had
to give the correct anticipated results and all human sam-
ples—but no apple sections—had to be positive for h-globin
DNA, for an individual PCR ‘run’ to be accepted); and (v) to
avoid the potential for cross-contamination, MMTV DNA
was not introduced into the laboratory until all experiments
on human cell lines and clinical samples had been completed.
PCR products were electrophoresed into 1.8% (w/v) agarose
gels containing ethidium bromide and visualised by epi-
illumination with UV light.
Restriction fragment length polymorphism (RFLP) analyses
of PCR products
The PCR amplifies a region of the env/pol genes of
MMTVs and HMLVs between nucleotides 6063 and 6719
(Fig. 6). The three reported HMLV DNA sequences (A, B,
and C; Table 4) corresponding to this region should be
distinguishable from one another by the presence of three
restriction endonuclease (RE) cut sites: HMLV sequence A
contains an Ase1 site which is not present in other docu-
mented HMLV or MMTV sequences; only sequence B
contains an Msp1 site; and sequence C has a BamH1 site
(as have nine MMTV sequences; Table 4 and Fig. 7). PCR
products of 25-Al volume reactions were digested with 0.5
units of RE (New England Biolabs Ltd.) for 12 h at 37 jC in
the appropriate buffer. All REwere checked before use for the
appropriate enzymatic activity and specificity by digesting a
segment of unrelated DNA known to contain the appropriate
cleavage sites.
DNA sequencing
Amplicons from HMLV PCRs were ligated into TOPO-
TA (Invitrogen Ltd.), transfected into E. coli (Top10 cells;
Invitrogen Ltd.), and grown overnight at 37 jC. Positivecolonies were identified, inoculated into 96-well plates con-
taining LB agar, and then sent to a commercial company
(Lark Technologies Ltd.) for DNA sequencing using a T3
primer.Acknowledgments
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